难治性脑血管痉挛患者重复即刻血管内干预的可行性与安全性
单中心回顾性研究纳入动脉瘤性蛛网膜下腔出血后难治性脑血管痉挛需≥3次血管内干预的患者31例(8.5%),末次随访时58%预后良好(mRS≤2),与≤2次干预者的61%无显著差异(P=.82);初始Hunt-Hess评分≤2是预后良好的独立预测因子(OR 4.7), eloquent区梗死与不良预后显著相关(OR 13.5)。
要点
- 动脉瘤性蛛网膜下腔出血后难治性脑血管痉挛需≥3次血管内干预者占8.5%(31/365)。
- ≥3次干预者末次随访良好预后(mRS≤2)比例为58%,与≤2次干预者的61%无显著差异(P=.82)。
- 初始Hunt-Hess评分≤2与良好预后独立相关(OR 4.7,95%CI 1.2-18.5,P=.03), eloquent区梗死与不良预后相关(OR 13.5,95%CI 2.3-81.2,P=.004)。
核心结论
- 重复即刻血管内干预是一种积极但可行的最后手段治疗策略,在已启动血管内治疗的难治性脑血管痉挛患者中约三分之二获得良好预后。
研究设计与样本
- 单中心回顾性研究,前瞻性收集数据;4年间共治疗365例动脉瘤性蛛网膜下腔出血患者,31例(8.5%)符合纳入标准(难治性脑血管痉挛需≥3次血管内干预);主要终点为末次随访功能预后(mRS≤2),次要终点为血管造影反应和脑梗死出现。
诊断标准与关键数值
- 良好预后定义为末次随访mRS≤2。
- ≥3次干预组良好预后18例(58%),≤2次干预组31例(61%),两组比较P=.82。
- 初始Hunt-Hess评分≤2预测良好预后:OR 4.7(95%CI 1.2-18.5),P=.03。
- eloquent区梗死与不良预后(mRS 3-6)相关:OR 13.5(95%CI 2.3-81.2),P=.004。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: For patients with cerebral vasospasm refractory to medical and hemodynamic therapies, endovascular therapies often remain the last resort. Data from studies in large cohorts on the efficacy and safety of multiple immediate endovascular interventions are sparse. Our aim was to assess the feasibility and safety of multiple repeat instant endovascular interventions in patients with cerebral vasospasm refractory to medical, hemodynamic, and initial endovascular interventions.
MATERIALS AND METHODS: This was a single-center retrospective study of prospectively collected data on patients with cerebral vasospasm refractory to therapies requiring ≥3 endovascular interventions during the course of treatment following aneurysmal subarachnoid hemorrhage. The primary end point was functional outcome at last follow-up (mRS ≤2). The secondary end point was angiographic response to endovascular therapies and the appearance of cerebral infarctions.
RESULTS: During a 4-year period, 365 patients with aneurysmal subarachnoid hemorrhage were treated at our institution. Thirty-one (8.5%) met the inclusion criteria. In 52 (14%) patients, ≤2 endovascular interventions were performed as rescue therapy for refractory cerebral vasospasm. At last follow-up, a good outcome was noted in 18 (58%) patients with ≥3 interventions compared with 31 (61%) of those with ≤2 interventions (P = .82). The initial Hunt and Hess score of ≤2 was a significant independent predictor of good outcome (OR, 4.7; 95% CI, 1.2-18.5; P = .03), whereas infarcts in eloquent brain areas were significantly associated with a poor outcome (mRS 3-6; OR, 13.5; 95% CI, 2.3-81.2; P = .004).
CONCLUSIONS: Repeat instant endovascular intervention is an aggressive but feasible last resort treatment strategy with a favorable outcome in two-thirds of patients with refractory cerebral vasospasm and in whom endovascular treatment has already been initiated.
引用
- Andereggen L, Beck J, Z'Graggen WJ, et al. Feasibility and Safety of Repeat Instant Endovascular Interventions in Patients with Refractory Cerebral Vasospasms. AJNR Am J Neuroradiol. 2016. PMID: 27979797. doi:10.3174/ajnr.A5024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。